Credit Suisse
-
The future of Credit Suisse’s investment bank hinges on driving revenue growth in concern with its wealth management division while improving its standing in corporate finance, writes David Rothnie -
New hire Eric Francois was most recently CFO of a biotech company
-
The majority shareholders of the Swiss pharma chemicals firm sold Sfr171 of shares at the end of the post-IPO lockup
-
The Swiss issuer landed attractive pricing despite recent volatility
-
Move follows poaching of FIG investment banking team in summer
-
Move follows absorption of Deutsche Bank business
-
New organisational structure to take effect at investment bank in January
-
Bolivia-headquartered Fonplata raises Sfr150m shortly after upgrade from S&P
-
South American supra is hitting its operational and lending targets
-
The cybersecurity firm has listed in London and Moscow
-
Three large borrowers latched on to a stronger backdrop to raise €4.5bn of funding
-
Swiss medical equipment firm is expected to list this week
